Rudy Li
Stock Analyst at Chardan Capital
(4.93)
# 30
Out of 5,058 analysts
30
Total ratings
80%
Success rate
69.98%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rudy Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Maintains: Buy | $80 → $330 | $189.32 | +74.31% | 3 | Oct 17, 2025 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $55 | $40.65 | +35.30% | 4 | Oct 7, 2025 | |
| IMUX Immunic | Initiates: Buy | $3 | $0.71 | +320.58% | 1 | Sep 29, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $15 | $15.54 | -3.47% | 1 | Sep 29, 2025 | |
| RVPH Reviva Pharmaceuticals Holdings | Initiates: Buy | $2 | $0.50 | +301.53% | 1 | Sep 29, 2025 | |
| PRTA Prothena Corporation | Maintains: Buy | $18 | $9.98 | +80.32% | 7 | Aug 28, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $24 | $28.48 | -15.73% | 4 | Aug 13, 2025 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $30 | $28.00 | +7.14% | 3 | Aug 12, 2025 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $20 | $10.93 | +82.98% | 4 | Aug 1, 2025 | |
| DRUG Bright Minds Biosciences | Maintains: Buy | $80 | $58.29 | +37.24% | 2 | May 21, 2025 |
Praxis Precision Medicines
Oct 17, 2025
Maintains: Buy
Price Target: $80 → $330
Current: $189.32
Upside: +74.31%
Xenon Pharmaceuticals
Oct 7, 2025
Maintains: Buy
Price Target: $55
Current: $40.65
Upside: +35.30%
Immunic
Sep 29, 2025
Initiates: Buy
Price Target: $3
Current: $0.71
Upside: +320.58%
Alto Neuroscience
Sep 29, 2025
Initiates: Buy
Price Target: $15
Current: $15.54
Upside: -3.47%
Reviva Pharmaceuticals Holdings
Sep 29, 2025
Initiates: Buy
Price Target: $2
Current: $0.50
Upside: +301.53%
Prothena Corporation
Aug 28, 2025
Maintains: Buy
Price Target: $18
Current: $9.98
Upside: +80.32%
Stoke Therapeutics
Aug 13, 2025
Maintains: Buy
Price Target: $24
Current: $28.48
Upside: -15.73%
Centessa Pharmaceuticals
Aug 12, 2025
Maintains: Buy
Price Target: $30
Current: $28.00
Upside: +7.14%
Mind Medicine (MindMed)
Aug 1, 2025
Maintains: Buy
Price Target: $20
Current: $10.93
Upside: +82.98%
Bright Minds Biosciences
May 21, 2025
Maintains: Buy
Price Target: $80
Current: $58.29
Upside: +37.24%